Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while removing specific details about states, cities, and previously listed location countries.
    Difference
    10%
    Check dated 2025-08-31T00:59:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T18:55:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T14:57:20.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.10) and the status of Zai Lab (Hong Kong), Ltd. is now listed as 'Unknown'.
    Difference
    8%
    Check dated 2025-08-02T13:55:33.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T12:12:25.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-19T10:50:35.000Z thumbnail image

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.